Man Group PLC Pfizer Inc Call Options Transaction History

Man Group PLC

4 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$27.7 - $31.39 $33,240 - $37,668	1,200 Added 0.88%	138,100 $4 Million
Q2 2024 Aug 14, 2024	BUY	$25.26 - $29.6 $901,782 - $1.06 Million	35,700 Added 35.28%	136,900 $3.83 Million
Q1 2024 May 15, 2024	SELL	$25.89 - $29.73 $310,680 - $356,760	-12,000 Reduced 10.6%	101,200 $2.81 Million
Q4 2023 Feb 14, 2024	BUY	$26.13 - $33.94 $2.96 Million - $3.84 Million	113,200 New	113,200 $3.26 Million

3,260

3.61B

77.2M

122M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $150B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Man Group PLC, based on Form 13F filings with the SEC.

Stay updated on Man Group PLC with notifications on news.